<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01776112</url>
  </required_header>
  <id_info>
    <org_study_id>UMCG-EX-II</org_study_id>
    <nct_id>NCT01776112</nct_id>
  </id_info>
  <brief_title>Enhancing Synaptic Plasticity and Cognition in Schizophrenia</brief_title>
  <acronym>EXERCISE-II</acronym>
  <official_title>Enhancing Synaptic Plasticity and Cognition by Physical Exercise and Cognitive Training in Schizophrenia: A Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Center Goettingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medical Center Goettingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To explore: (a) if physical exercise (sports) combined with cognitive training leads to
      (superior) improvement of cognition in schizophrenia compared to sports or cognitive training
      alone (b) if a sports program alone or in combination with cognitive training has influence
      on hippocampal pathology and synaptic plasticity in schizophrenia compared to a placebo
      condition.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">August 2014</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hippocampal volume</measure>
    <time_frame>after three months of exercise</time_frame>
    <description>Measurement of hippocampal volume before and after the exercise intervention, 3T-MRI MPRAGE-Sequence, manual and automated delineation of hippocampal borders</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Verbal Learning Memory</measure>
    <time_frame>after three months of exercise</time_frame>
    <description>Neuropsychological assessment of a working memory domain via the Verbal Learning Memory Test (German: Helmstaedter, C., Lendt, M., Lux, S., 2001. Verbaler Lern- und Merkfähigkeitstest (VLMT). Göttingen, Beltz)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positive and negative symptoms</measure>
    <time_frame>after three months of exercise</time_frame>
    <description>Measurement of positive and negative symptoms of schizophrenia using the &quot;Positive and Negative Symptom Scale for Schizophrenia&quot; (Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261-76)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">66</enrollment>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>SZ-Exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard treatment and participation in the sports program (cycling) including cognitive training, 3 sessions cycling (30 min. each) per week for 3 months and 2 sessions Cogpack per week for the last 6 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SZ-TableSoccer</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Standard treatment and participation in an activity without physical improvement as placebo condition (table soccer in groups of 4), but including cognitive training, 3 sessions (30 min. each) per week for 3 months and 2 sessions Cogpack per week for the last 6 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HC-Exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard treatment and participation in an activity without physical improvement as placebo condition (table football in groups of 4), but including cognitive training, 3 sessions (30 min. each) per week for 3 months and 2 sessions Cogpack per week for the last 6 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>Standard treatment and participation in the sports program (cycling) including cognitive training, 3 sessions cycling (30 min. each) per week for 3 months and 2 sessions Cogpack per week for the last 6 weeks.</description>
    <arm_group_label>SZ-Exercise</arm_group_label>
    <arm_group_label>HC-Exercise</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>TableSoccer</intervention_name>
    <description>Standard treatment and participation in an activity without physical improvement as placebo condition (table football in groups of 4), but including cognitive training, 3 sessions (30 min. each) per week for 3 months and 2 sessions Cogpack per week for the last 6 weeks.</description>
    <arm_group_label>SZ-TableSoccer</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female patients with the diagnosis of schizophrenia (based on ICD-10
             criteria)

          -  Age between 18 and 55

          -  Verbal IQ ≥ 85

          -  Stable psychopathology on constant medication for 2 weeks

          -  Informed consent.

        Exclusion Criteria:

        Patients, who are

          -  not willing or able to participate in the sports program and cognitive training

          -  reveal a significant worsening of psychopathology (based on an increase over 20% of
             the PANSS positive score)

          -  have an organic mental disorder (such as intoxication or neurological disorders of the
             CNS)

          -  suffer from instable somatic diseases

          -  have an active substance abuse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Falkai, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Head, Dept. of Psychiatry and Psychotherapy University Medical Center Goettingen Georg-August-University von-Siebold-Strasse 5 D-37075 Goettingen Germany P: +49-(0)551-39-6610</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andrea Schmitt, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Professor, Dept. of Psychiatry and Psychotherapy University Medical Center Goettingen Georg-August-University von-Siebold-Strasse 5 D-37075 Goettingen Germany P: +49-(0)551-39-6610</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Berend Malchow, MD</last_name>
    <role>Study Director</role>
    <affiliation>Senior Consultant, Dept. of Psychiatry and Psychotherapy University Medical Center Goettingen Georg-August-University von-Siebold-Strasse 5 D-37075 Goettingen Germany P: +49-(0)551-39-6610</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dept. of Psychiatry and Psychotherapy, University Medical Center Goettingen, Georg-August-University</name>
      <address>
        <city>Goettingen</city>
        <state>Lower Saxony</state>
        <zip>37075</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Pajonk FG, Wobrock T, Gruber O, Scherk H, Berner D, Kaizl I, Kierer A, Müller S, Oest M, Meyer T, Backens M, Schneider-Axmann T, Thornton AE, Honer WG, Falkai P. Hippocampal plasticity in response to exercise in schizophrenia. Arch Gen Psychiatry. 2010 Feb;67(2):133-43. doi: 10.1001/archgenpsychiatry.2009.193.</citation>
    <PMID>20124113</PMID>
  </reference>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 1, 2012</study_first_submitted>
  <study_first_submitted_qc>January 22, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 25, 2013</study_first_posted>
  <last_update_submitted>May 26, 2015</last_update_submitted>
  <last_update_submitted_qc>May 26, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Medical Center Goettingen</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Peter Falkai</investigator_full_name>
    <investigator_title>Prof. Dr. med. Peter Falkai</investigator_title>
  </responsible_party>
  <keyword>schizophrenia</keyword>
  <keyword>negative symptoms</keyword>
  <keyword>cognitive deficits</keyword>
  <keyword>synaptic plasticity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

